vimarsana.com
Home
Live Updates
Prothena Presents New Preclinical Data Supporting Best-in-Cl
Prothena Presents New Preclinical Data Supporting Best-in-Cl
Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023
Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding... | March 31, 2023
Related Keywords
Sweden ,
Gothenburg ,
Vastra Gotalands Lan ,
Wagner Zago ,
Prothena Corporation ,
International Conference On Alzheimer ,
Exchange Commission ,
Nasdaq ,
Forum Discussions ,
Company On Twitter Prothenacorp ,
Plasmon Resonance ,
Chief Scientific Officer ,
Prothena Activities ,
Disease Modifying Treatments ,
Taking Stock ,
Two Forum Discussions ,
From Basics ,
Anti Tau Therapies ,
Clinical Trials ,
Annual Report ,
Prothena Corporation Plc Stock Exchange ,
News ,
Information ,
Press Release ,
Data ,
Rom ,
Mural ,
Presentation ,
Odds ,
O ,
Rowing ,
Body ,
F ,
Evidence ,
Supporting ,
The ,
Profile ,
Which ,
Us ,
Esigned ,
Target ,
Wall ,
Aggregated ,
Eforms ,
Amyloid ,
Meta ,
Ith ,
Igh Prta Ie00b91xrn20 ,